Back
Royalty Pharma PLC Stock Price Chart

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
RPRX
Royalty Pharma PLC
Last Price:
$31.38
Seasonality Move:
-2.74%
7 Day Trial
ALL ACCESS PASS
$
7

Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing slight selling pressure.
Royalty Pharma PLC Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.84 | Sell |
20-day SMA: | 32.99 | Sell |
50-day SMA: | 32.42 | Sell |
200-day SMA: | 28.45 | Buy |
8-day EMA: | 32.44 | Sell |
20-day EMA: | 32.75 | Sell |
50-day EMA: | 31.89 | Sell |
200-day EMA: | 29.45 | Buy |
Royalty Pharma PLC Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 35.44 | Sell |
Chaikin Money Flow: | -282065 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.41 - 33.81) | Sell |
Bollinger Bands (100): | (26.01 - 32.63) | Buy |
Royalty Pharma PLC Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Royalty Pharma PLC Stock
Is Royalty Pharma PLC Stock a Buy?
-
Royalty Pharma PLC share price is 31.37 while RPRX 8-day simple moving average is 32.84, which is a Sell signal.
-
The stock price of RPRX is 31.37 while Royalty Pharma PLC 20-day SMA is 32.99, which makes it a Sell.
-
Royalty Pharma PLC 50-day simple moving average is 32.42 while RPRX share price is 31.37, making it a Sell technically.
-
RPRX stock price is 31.37 and Royalty Pharma PLC 200-day simple moving average is 28.45, creating a Buy signal.
RPRX Technical Analysis vs Fundamental Analysis
Sell
28
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy or a Sell?
-
Royalty Pharma PLC stock is rated a SellThe current Royalty Pharma PLC [RPRX] share price is $31.37. The Score for RPRX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Royalty Pharma PLC Stock Info
Market Cap:
13.6B
Price in USD:
31.37
Share Volume:
4.1M
Royalty Pharma PLC 52-Week Range
52-Week High:
34.20
52-Week Low:
24.05
Sell
28
Royalty Pharma PLC (RPRX)
is a Sell
Royalty Pharma PLC Share Price Forecast
-
What is the Royalty Pharma PLC stock price today?The Royalty Pharma PLC stock price is 31.37 USD today.
-
Will RPRX stock go up or go down?Royalty Pharma PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Royalty Pharma PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Royalty Pharma PLC is overvalued.
Is Royalty Pharma PLC Stock a Buy?
-
Royalty Pharma PLC share price is 31.37 while RPRX 8-day exponential moving average is 32.44, which is a Sell signal.
-
The stock price of RPRX is 31.37 while Royalty Pharma PLC 20-day EMA is 32.75, which makes it a Sell.
-
Royalty Pharma PLC 50-day exponential moving average is 31.89 while RPRX share price is 31.37, making it a Sell technically.
-
RPRX stock price is 31.37 and Royalty Pharma PLC 200-day simple moving average is 29.45, creating a Buy signal.
Fundamental Analysis of Royalty Pharma PLC
Is Royalty Pharma PLC a good investment?
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.18 per share, an increase this year of $0.62 per share, and an increase next year of $0.31 per share.
Technical Analysis of Royalty Pharma PLC
Should I short Royalty Pharma PLC stock?
-
RPRX Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Royalty Pharma PLC is a Sell
-
Royalty Pharma PLC Relative Strength Index (RSI) is 35.44, which suggest Royalty Pharma PLC is oversold
-
The Bollinger Bands (25) for Royalty Pharma PLC is (32.41 - 33.81), which suggest Royalty Pharma PLC is a Buy
-
The Bollinger Bands (100) for Royalty Pharma PLC is (26.01 - 32.63), which suggest Royalty Pharma PLC is a Buy
* Royalty Pharma PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.